| Primary |
| Pain |
28.3% |
| Drug Use For Unknown Indication |
21.3% |
| Product Used For Unknown Indication |
20.7% |
| Back Pain |
6.7% |
| Cancer Pain |
3.8% |
| Drug Abuse |
3.0% |
| Procedural Pain |
2.1% |
| Analgesic Therapy |
2.0% |
| Anaesthesia |
1.9% |
| Drug Abuser |
1.6% |
| Spinal Anaesthesia |
1.1% |
| Pain In Extremity |
1.0% |
| Pain Management |
1.0% |
| Breakthrough Pain |
0.9% |
| Arthralgia |
0.9% |
| Depression |
0.8% |
| Hypertension |
0.8% |
| Abdominal Pain |
0.8% |
| Neuralgia |
0.8% |
| Prophylaxis |
0.7% |
|
| Drug Hypersensitivity |
25.2% |
| Death |
10.4% |
| Vomiting |
7.6% |
| Drug Abuse |
6.1% |
| Product Quality Issue |
6.0% |
| Overdose |
4.5% |
| Pharmaceutical Product Complaint |
4.2% |
| Respiratory Arrest |
4.2% |
| Unresponsive To Stimuli |
4.1% |
| Substance Abuse |
3.7% |
| Somnolence |
3.7% |
| Toxicity To Various Agents |
3.6% |
| Acute Chest Syndrome |
2.9% |
| Pain |
2.5% |
| Drug Ineffective |
2.2% |
| Medication Error |
2.0% |
| Pruritus |
1.9% |
| Drug Interaction |
1.7% |
| Urticaria |
1.7% |
| Weight Decreased |
1.7% |
|
| Secondary |
| Product Used For Unknown Indication |
29.6% |
| Pain |
25.2% |
| Drug Use For Unknown Indication |
12.4% |
| Back Pain |
6.9% |
| Cancer Pain |
5.3% |
| Hypertension |
2.1% |
| Analgesic Therapy |
2.0% |
| Osteoarthritis |
1.7% |
| Neuralgia |
1.7% |
| Breakthrough Pain |
1.6% |
| Depression |
1.4% |
| Drug Abuser |
1.3% |
| Rheumatoid Arthritis |
1.3% |
| Prophylaxis |
1.2% |
| Anxiety |
1.1% |
| Drug Abuse |
1.1% |
| Pain In Extremity |
1.1% |
| Nausea |
1.0% |
| Symphysiolysis |
1.0% |
| Fibromyalgia |
1.0% |
|
| Drug Hypersensitivity |
20.7% |
| Vomiting |
13.8% |
| Somnolence |
7.0% |
| Substance Abuse |
5.8% |
| Toxicity To Various Agents |
5.1% |
| Weight Decreased |
5.1% |
| Renal Failure Acute |
4.4% |
| Unresponsive To Stimuli |
4.3% |
| Pain |
3.6% |
| Death |
3.4% |
| Overdose |
3.3% |
| Respiratory Depression |
2.9% |
| Drug Ineffective |
2.8% |
| Asthenia |
2.7% |
| Cardio-respiratory Arrest |
2.6% |
| Hyperaesthesia |
2.6% |
| Respiratory Arrest |
2.6% |
| Tremor |
2.6% |
| Withdrawal Syndrome |
2.6% |
| Drug Abuse |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.1% |
| Drug Use For Unknown Indication |
21.5% |
| Pain |
12.1% |
| Prophylaxis |
3.8% |
| Multiple Myeloma |
3.8% |
| Hypertension |
3.6% |
| Constipation |
2.8% |
| Nausea |
2.7% |
| Depression |
2.3% |
| Rheumatoid Arthritis |
2.1% |
| Surgery |
2.1% |
| Non-small Cell Lung Cancer |
2.0% |
| Back Pain |
1.6% |
| Prostate Cancer |
1.6% |
| Abdominal Pain |
1.6% |
| Anxiety |
1.5% |
| Hiv Infection |
1.5% |
| Insomnia |
1.2% |
| Thrombosis Prophylaxis |
1.1% |
| Gastrooesophageal Reflux Disease |
1.0% |
|
| Vomiting |
19.2% |
| Weight Decreased |
10.7% |
| Death |
8.1% |
| Weight Increased |
5.5% |
| Pulmonary Embolism |
5.4% |
| Thrombocytopenia |
4.9% |
| Pyrexia |
4.7% |
| Pneumonia |
4.5% |
| Renal Failure Acute |
4.5% |
| Urinary Tract Infection |
4.4% |
| Sepsis |
4.3% |
| Pain |
3.5% |
| Renal Failure |
2.9% |
| Nausea |
2.7% |
| Respiratory Failure |
2.7% |
| Somnolence |
2.7% |
| Wheezing |
2.5% |
| Dehydration |
2.3% |
| Oedema Peripheral |
2.3% |
| Dyspnoea |
2.3% |
|
| Interacting |
| Pain |
31.6% |
| Product Used For Unknown Indication |
22.2% |
| Back Pain |
10.5% |
| Cancer Pain |
5.5% |
| Endocarditis |
3.6% |
| Analgesic Therapy |
3.3% |
| Premedication |
2.5% |
| Bipolar Disorder |
2.2% |
| Constipation |
2.2% |
| Restlessness |
2.2% |
| Anaesthesia |
1.8% |
| Hypertension |
1.8% |
| Anxiety |
1.5% |
| Diabetes Mellitus |
1.5% |
| Gastric Ulcer |
1.5% |
| Lung Disorder |
1.5% |
| Urinary Tract Infection |
1.5% |
| Fibromyalgia |
1.1% |
| Hepatitis C |
1.1% |
| Neuralgia |
1.1% |
|
| Sedation |
17.9% |
| Drug Interaction |
16.4% |
| Somnolence |
10.4% |
| Advanced Sleep Phase |
6.0% |
| Dyspnoea |
4.5% |
| Respiratory Failure |
4.5% |
| Suicidal Ideation |
4.5% |
| Acute Respiratory Failure |
3.0% |
| Agitation |
3.0% |
| Depression |
3.0% |
| Dizziness |
3.0% |
| Drug Tolerance |
3.0% |
| Grand Mal Convulsion |
3.0% |
| Nightmare |
3.0% |
| Oliguria |
3.0% |
| Sepsis |
3.0% |
| Toxicity To Various Agents |
3.0% |
| Withdrawal Syndrome |
3.0% |
| Adverse Drug Reaction |
1.5% |
| Blood Potassium Decreased |
1.5% |
|
